Found: 27
Select item for more details and to access through your institution.
The association between diabetes related medical costs and glycemic control: A retrospective analysis.
- Published in:
- Cost Effectiveness & Resource Allocation, 2006, v. 4, p. 1, doi. 10.1186/1478-7547-4-1
- By:
- Publication type:
- Article
Impact of Early Versus Late Systemic Lupus Erythematosus Diagnosis on Clinical and Economic Outcomes.
- Published in:
- Applied Health Economics & Health Policy, 2014, v. 12, n. 2, p. 179, doi. 10.1007/s40258-014-0085-x
- By:
- Publication type:
- Article
Demographic and Clinical Characteristics of Patients with Diabetic Retinopathy in Managed Care Health Plans in the United States.
- Published in:
- Diabetes, 2007, v. 56, p. A614
- By:
- Publication type:
- Article
Changes in Concomitant Diabetes Therapies Associated with the Initiation of Exenatide in Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A561
- By:
- Publication type:
- Article
Administrative Claims Analysis of New Exenatide Patients with Type 2 Diabetes.
- Published in:
- Diabetes, 2007, v. 56, p. A561
- By:
- Publication type:
- Article
Direct and Indirect Costs Among Employees with Diabetic Retinopathy.
- Published in:
- Diabetes, 2007, v. 56, p. A216
- By:
- Publication type:
- Article
The Link Between Visual Acuity and Health-Related Quality of Life Among Patients with Diabetic Retinopathy.
- Published in:
- Diabetes, 2007, v. 56, p. A216
- By:
- Publication type:
- Article
Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 8, p. 1, doi. 10.1093/ofid/ofab363
- By:
- Publication type:
- Article
2512. Decreasing Adherence to Antiretroviral Therapy over 4 Years of Follow-up in a Commercially-Insured Population of Patients with HIV.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S872, doi. 10.1093/ofid/ofz360.2190
- By:
- Publication type:
- Article
2485. Real-world Experience with Dolutegravir Plus Rilpivirine Two-Drug Regimen.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S861, doi. 10.1093/ofid/ofz360.2163
- By:
- Publication type:
- Article
2488. Virologic Failure in ART Naïve Patients Initiating on a Dolutegravir or Elvitegravir-Based Regimen.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S862, doi. 10.1093/ofid/ofz360.2166
- By:
- Publication type:
- Article
2484. Patient Reported Outcomes After Switching to a 2-Drug Regimen of Dolutegravir + Rilpivirine: Week 148 Results from the Sword-1 and Sword-2 Studies.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S861, doi. 10.1093/ofid/ofz360.2162
- By:
- Publication type:
- Article
Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 6, p. 1422, doi. 10.1002/art.39601
- By:
- Publication type:
- Article
Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancer.
- Published in:
- Quality of Life Research, 2013, v. 22, n. 5, p. 1105, doi. 10.1007/s11136-012-0217-4
- By:
- Publication type:
- Article
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 4, p. 891, doi. 10.1007/s40121-024-00961-y
- By:
- Publication type:
- Article
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 4, p. 875, doi. 10.1007/s40121-024-00950-1
- By:
- Publication type:
- Article
Comparing Real-World Healthcare Costs Associated with Single-Tablet Regimens for HIV-1: The 2-Drug Regimen Dolutegravir/Lamivudine vs. Standard 3- or 4-Drug Regimens.
- Published in:
- Infectious Diseases & Therapy, 2023, v. 12, n. 8, p. 2117, doi. 10.1007/s40121-023-00848-4
- By:
- Publication type:
- Article
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study.
- Published in:
- Infectious Diseases & Therapy, 2020, v. 9, n. 1, p. 41, doi. 10.1007/s40121-019-00274-5
- By:
- Publication type:
- Article
A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma.
- Published in:
- Sarcoma, 2016, p. 1, doi. 10.1155/2016/3597609
- By:
- Publication type:
- Article
Optimization of BMD Measurements to Identify High Risk Groups for Treatment-A Test Analysis.
- Published in:
- Journal of Bone & Mineral Research, 2004, v. 19, n. 6, p. 906, doi. 10.1359/jbmr.2004.19.6.906
- By:
- Publication type:
- Article
The health care costs of diabetic peripheral neuropathy in the US.
- Published in:
- 2003
- By:
- Publication type:
- journal article
The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.
- Published in:
- Diabetes Care, 2003, v. 26, n. 6, p. 1790, doi. 10.2337/diacare.26.6.1790
- By:
- Publication type:
- Article
Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes.
- Published in:
- Health & Quality of Life Outcomes, 2006, v. 4, p. 80, doi. 10.1186/1477-7525-4-80
- By:
- Publication type:
- Article
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 4, p. 447, doi. 10.1007/s40273-023-01342-y
- By:
- Publication type:
- Article
Real-World Experience with Dolutegravir-Based Two-Drug Regimens.
- Published in:
- AIDS Research & Treatment, 2020, p. 1, doi. 10.1155/2020/5923256
- By:
- Publication type:
- Article
Benchmarking HIV Quality Measures Across US Payer Types.
- Published in:
- Population Health Management, 2020, v. 23, n. 2, p. 146, doi. 10.1089/pop.2019.0052
- By:
- Publication type:
- Article
Predicted Costs and Outcomes From Reduced Vibration Detection in People With Diabetes in the U.S.
- Published in:
- Diabetes Care, 2003, v. 26, n. 8, p. 2305, doi. 10.2337/diacare.26.8.2305
- By:
- Publication type:
- Article